Gross Profit Margin (Quarterly) Chart

Historical Gross Profit Margin (Quarterly) Data

View and export this data back to 2000. Start Trial.
Date Value
June 30, 2026 66.57%
March 31, 2026 69.34%
December 31, 2025 68.09%
September 30, 2025 68.17%
June 30, 2025 65.16%
March 31, 2025 66.75%
December 31, 2024 63.64%
September 30, 2024 64.13%
June 30, 2024 63.10%
March 31, 2024 65.80%
December 31, 2023 62.75%
September 30, 2023 61.71%
June 30, 2023 62.29%
March 31, 2023 64.75%
December 31, 2022 61.73%
September 30, 2022 60.26%
June 30, 2022 61.34%
March 31, 2022 63.98%
December 31, 2021 63.79%
September 30, 2021 60.24%
June 30, 2021 58.29%
March 31, 2021 61.70%
December 31, 2020 58.43%
September 30, 2020 55.44%
June 30, 2020 56.48%
Date Value
March 31, 2020 61.19%
December 31, 2019 58.32%
September 30, 2019 60.35%
June 30, 2019 50.83%
March 31, 2019 61.36%
December 31, 2018 55.15%
September 30, 2018 56.43%
June 30, 2018 53.99%
March 31, 2018 58.51%
December 31, 2017 64.48%
September 30, 2017 57.57%
June 30, 2017 56.87%
March 31, 2017 61.98%
December 31, 2016 65.12%
September 30, 2016 65.40%
June 30, 2016 65.46%
March 31, 2016 70.99%
December 31, 2015 70.45%
September 30, 2015 69.12%
June 30, 2015 61.59%
March 31, 2015 67.69%
December 31, 2014 69.44%
September 30, 2014 64.75%
June 30, 2014 69.76%
March 31, 2014 73.83%

Gross Profit Margin Definition

Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.

Read full definition.

Gross Profit Margin (Quarterly) Range, Past 5 Years

View Gross Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit Margin (Quarterly) Benchmarks

View Gross Profit Margin (Quarterly) Benchmarks
Start Trial
Novo Nordisk A/S 78.21%
H. Lundbeck A/S 79.00%
AstraZeneca PLC 76.09%
ANI Pharmaceuticals, Inc. 54.97%
Corcept Therapeutics, Inc. 98.41%

Gross Profit Margin (Quarterly) Related Metrics